Correlation Between Alto Neuroscience, and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and DiaMedica Therapeutics, you can compare the effects of market volatilities on Alto Neuroscience, and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and DiaMedica Therapeutics.
Diversification Opportunities for Alto Neuroscience, and DiaMedica Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alto and DiaMedica is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and DiaMedica Therapeutics
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the DiaMedica Therapeutics. In addition to that, Alto Neuroscience, is 1.74 times more volatile than DiaMedica Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 370.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 146.00 from holding DiaMedica Therapeutics or generate 39.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 61.65% |
Values | Daily Returns |
Alto Neuroscience, vs. DiaMedica Therapeutics
Performance |
Timeline |
Alto Neuroscience, |
DiaMedica Therapeutics |
Alto Neuroscience, and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alto Neuroscience, and DiaMedica Therapeutics
The main advantage of trading using opposite Alto Neuroscience, and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.Alto Neuroscience, vs. Equillium | Alto Neuroscience, vs. DiaMedica Therapeutics | Alto Neuroscience, vs. Valneva SE ADR | Alto Neuroscience, vs. Vivani Medical |
DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets |